Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living with rare diseases, and Protalix BioTherapeutics, Inc.
With this in mind, microbiologist professor Brenda Wilson of the University of Illinois Urbana-Champaign, has shared what you ...
Antibiotic resistance is one of the biggest health threats of our time—and tackling it will take more than a single ...
News-Medical.Net on MSN
Estradiol and estriol may protect nerve function in multiple sclerosis
About 100,000 of the estimated million people in the United States with multiple sclerosis (MS) have a progressive form of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback